Market evolution: Amino alcohols (CN 292219) — 2015–2025

Introduction

This report examines the evolution of EU external trade in products classified under customs code 292219 — a residual category covering amino-alcohols, their ethers and esters, and salts thereof, excluding several well-known substances such as monoethanolamine, diethanolamine, and triethanolamine. These chemicals serve primarily as intermediates in the pharmaceutical, agrochemical, and specialty-chemical industries.

Over the 2015–2025 period, the EU's position in this market underwent a profound structural transformation. A trade surplus of nearly €574 million at the start of the period shrank to roughly €52 million by 2025, driven principally by a dramatic collapse in exports from a single EU member state. Meanwhile, import volumes surged by over 70%, prices on both sides of the trade ledger fell by roughly half, and the supplier landscape shifted markedly toward Asian producers. The following sections unpack these dynamics in detail.

For full product definitions and time-series charts, see the product overview dashboard.

1. Ireland's Collapse Redrew the EU's Export Map

The single most consequential development in the EU amino-alcohol market over the past decade was the near-total disappearance of Irish exports. Ireland, which dominated EU outbound trade in this product at the start of the period, virtually exited the market by its end — a shift that single-handedly reshaped the EU's overall trade balance.

Ireland accounted for almost the entire export decline

In 2015, Ireland's exports of CN 292219 products stood at approximately €569 million, representing roughly 63% of total EU exports (€905 million). By 2025, Irish exports had fallen to just €2.5 million — a decline of 99.6%. The total EU export value over the same period fell from €905 million to €365 million, a drop of €541 million. Ireland's own decline of approximately €567 million thus exceeded the entire EU-wide contraction, meaning that other EU member states actually grew their combined exports during this period.

Source: top reporters by value (exports)

Ireland's outsized role was almost certainly linked to its large pharmaceutical manufacturing base, where amino-alcohols serve as key intermediates. The collapse may reflect the relocation of specific production lines, patent expirations reducing demand for particular active ingredients, or corporate restructuring among multinationals with Irish operations.

The US was the primary destination affected

The destination most impacted by the Irish export decline was the United States. EU exports to the US fell from €631.8 million in 2015 to just €55.9 million in 2025 (−91.2%), a drop of €576 million. Given Ireland's dominance of total EU exports and the US's dominance as a destination, it is highly likely that the bulk of Ireland's 2015 output was shipped to American pharmaceutical or chemical customers.

Other major export destinations held up considerably better:

Source: top partners by value (exports)

Notably, exports to India grew by 44.3%, and those to the UK and Korea also increased, suggesting that EU producers outside Ireland maintained competitive positions in diverse markets.

Export prices fell in line with a global repricing

Export unit values declined from €13,790 per tonne in 2015 to €6,220 per tonne in 2025, a drop of 54.9%. However, export volumes contracted by only 10.8% (from 65,649 tonnes to 58,572 tonnes). This indicates that the value decline was overwhelmingly a price phenomenon rather than a volume one. The repricing likely reflects a combination of product-mix shifts (as Ireland's high-value pharmaceutical intermediates exited the data) and broader global price compression in amino-alcohol markets. A notable price shock is recorded for UK export prices in 2017, with a 37.4% year-on-year shift and an abnormality score of 2,807 — the most extreme price event in the dataset (supply shock details).

2. Import Volumes Surged as Asian Suppliers Gained Ground

While the export side of the EU's amino-alcohol trade contracted, the import side told a contrasting story: volumes rose sharply even as values remained broadly stable, reflecting both structural demand growth within the EU and a decisive shift in the global supply landscape.

Quantities grew 72% while total value barely moved

EU imports of CN 292219 products rose from 27,796 tonnes in 2015 to 47,817 tonnes in 2025, an increase of 72.0%. Yet import value edged down by 5.6%, from €331 million to €313 million. This is explained entirely by the collapse in unit prices, which fell from €11,911 per tonne to €6,177 per tonne (−48.1%). Import prices thus converged with export prices by 2025 — both sitting near €6,200 per tonne — suggesting the emergence of a single global price benchmark rather than the differentiated pricing structure observed at the start of the period.

Source: trade overview

China and India emerged as the fastest-growing suppliers

The most striking shift in the import supply base was the rapid rise of China and India. Chinese exports to the EU nearly tripled, rising from €32.8 million to €84.6 million (+157.9%), while Indian shipments more than doubled from €18.4 million to €38.3 million (+108.1%). Together, these two countries accounted for €123 million of EU imports by 2025, up from just €51 million in 2015.

Source: top partners by value (imports)

The United States remained the single largest external supplier at €98.3 million, though its share of a relatively stable total import value meant it grew modestly (+19.8%). Switzerland, previously the second-largest source, declined from €49.8 million to €40.8 million and was overtaken by China. Swiss import flows were also the most volatile among major partners, with a coefficient of variation of 1.22 — indicating large year-to-year swings that may reflect re-export dynamics or pharmaceutical batch production (volatility details). A US import price shock in 2022, with a 65.3% year-on-year shift, likely reflects the post-COVID energy and supply-chain disruptions of that year.

EU import demand shifted geographically within the bloc

On the receiving side within the EU, Germany remained the largest importer throughout the period, growing from €73.7 million to €87.9 million (+19.3%). However, several other member states showed much faster growth:

Source: top reporters by value (imports)

Spain's imports nearly two-and-a-half-folded (+146.9%), and the Netherlands' nearly doubled (+91.1%). France, by contrast, saw a significant decline of 38.3%. Ireland's own imports of €28 million by 2025 are notable: a country that once exported €569 million of these products is now a net importer, underscoring the magnitude of the structural shift.

3. A Market in Structural Reorientation: From Net Exporter to Self-Sufficiency Frontier

Beyond the headline trade figures, deeper structural indicators reveal a market that has fundamentally reoriented itself. The EU moved from a position of strong net export surplus to the brink of net import dependence, even as domestic production grew. Specialisation and concentration patterns shifted in ways that reflect both the Ireland shock and broader competitive dynamics.

Domestic production expanded despite the export decline

EU production of CN 292219 products grew from 257.4 million kilograms to 300 million kilograms (+16.5%) over the period, with production value rising from €664 million to €740 million (+11.4%). This is a notable finding: even as exports collapsed by 60% in value, the EU's manufacturing base for these products expanded.

Source: production volumes

This divergence between production growth and export decline implies that a larger share of EU output is now consumed domestically — either by downstream chemical or pharmaceutical industries within the EU, or incorporated into finished products that are exported under different customs codes. Ireland's export drop may thus partly reflect a shift toward intra-EU supply chains rather than pure production loss.

Specialisation is concentrated in Western Europe

Analysis of revealed comparative advantage (RCA) for 2025 shows that amino-alcohol production and export specialisation is heavily concentrated in a handful of Western European economies:

Source: specialisation analysis

Belgium shows the highest RCA (2.29), indicating a strong relative specialisation in these products despite its modest absolute export share. Germany, by contrast, combines high specialisation with the largest absolute production and export footprint. Central and Eastern European members — including Romania (RCA 0.0003), Poland (RCA 0.014), and Croatia (RCA 0.006) — show virtually no presence in this market, reflecting the capital-intensive, knowledge-intensive nature of fine-chemical and pharmaceutical-intermediate production.

Export concentration collapsed; import concentration held steady

The Herfindahl-Hirschman Index (HHI) for export concentration fell from 5,002 to 898 over the period — an 82% decline that transforms the EU export structure from highly concentrated (dominated by Ireland) to moderately competitive. Import-side concentration, by contrast, remained broadly stable (HHI of 2,186 to 2,129), indicating that the supply base for EU imports was already diversified at the start of the period and did not undergo a comparable structural shift.

Source: concentration analysis

The dramatic de-concentration on the export side is a direct consequence of Ireland's exit. While this makes the EU export profile more resilient to single-country shocks, the simultaneous decline in total export value means the EU has lost pricing power and scale in global markets.

The EU crossed the threshold from net exporter to near-import dependence

Perhaps the most strategically significant finding is the shift in net import reliance. In 2015, the EU was a strong net exporter, with a net import reliance of −73.9% (meaning exports exceeded imports by nearly 74% of the import value). By 2025, this figure had narrowed to −3.8% — the EU was essentially in trade balance. At its most extreme, net import reliance turned positive at 13.8%, meaning the EU briefly became a net importer of these products.

Source: net import reliance, trade intensity, export propensity

Trade intensity (total trade relative to production) fell from 89.2% to 75.6%, and export propensity (exports relative to production) dropped from 84.6% to 61.5%. Both metrics indicate that the EU amino-alcohol market has become more inward-looking: more production is staying within the bloc, and the EU's global market footprint has contracted.

Conclusion

The EU trade in amino-alcohols (CN 292219) between 2015 and 2025 tells the story of a market profoundly reshaped by the near-total withdrawal of its dominant player. Ireland's export collapse — from €569 million to €2.5 million — accounts for virtually the entire decline in the EU's external trade surplus and its shift from a position of strong net export dominance to near balance.

Yet this headline narrative masks several countervailing trends. Other EU producers, particularly Germany, Belgium, the Netherlands, and Spain, expanded their exports and maintained competitive positions in global markets. Domestic production grew by over 16% in volume terms, suggesting that the underlying manufacturing base remains robust even as its external orientation has diminished. On the import side, the doubling of import volumes alongside a halving of unit prices points to increased reliance on cost-competitive Asian suppliers — notably China (+158%) and India (+108%) — who are reshaping the global supply landscape for these intermediates.

From a strategic standpoint, the EU has moved from a comfortable surplus position to a delicate equilibrium. With net import reliance at −3.8% and export propensity declining, the bloc's margin of self-sufficiency in amino-alcohols has narrowed considerably. Further erosion — whether through continued import growth, additional production relocations, or supply-chain disruptions from key partners — could push the EU into structural import dependence in a product category that underpins its pharmaceutical and chemical industries.